CBD-Intel will provide comprehensive market and legal analysis as well as a daily news service.
It is published by Tamarind Media, which since 2014 has been the leader in providing executive-level information and insight for the e-cigarette market through ECigIntelligence.
Like ECigIntelligence, CBD-Intel is based on a paid subscription model and accepts no advertising, guaranteeing its editorial independence.
It will provide unparalleled coverage by drawing on a team of more than 20 legal and market analysts, reporters and editors, with a permanent staff presence in Barcelona, London, Dublin and New York.
Further content will also be provided by correspondents on every continent.
“With ECigIntelligence we have found that a rapidly-developing industry has an urgent need for authoritative, unbiased, in-depth coverage of markets and regulation,” said managing director Tim Phillips.
“We believe that the CBD industry across Europe and the world will benefit from exactly the same approach – reporting and analysis that is intelligent, insightful and independent.”
CBD, or cannabidiol, is the legal extract of the cannabis plant which is becoming widely popular as a personal health product, used for a range of purposes including pain relief and the treatment of anxiety.
ECigIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of ECigIntelligence, does not accept any liability or responsibility for information or views published.
Please see this page for a detailed description of our methodology.